Bottom line
Is FGROX a good fund? The bottom line
FGROX is the Institutional Class share class of Emerald Growth Fund, a managed large growth mutual fund from Rbb.
Its expense ratio is 0.75% — about $75 a year on every $10,000 invested, cheaper than 59% of large growth funds we track.
It returned +32.0% over one year, +8.1% a year over five years, +12.7% a year over ten (as of Dec 31, 2025, per its prospectus).
With $1.5 billion in net assets and 132 holdings, its largest position is F/m Emerald Life Sciences Inno (6.1%) and the top 10 make up 21.4% of the portfolio.
What stands out
- No front-end sales load
Updated Nov 19, 2026
What FGROX invests in
Emerald Growth Fund (the Fund) seeks long-term growth through capital appreciation.
The Fund has adopted an investment policy that it will, under normal conditions, invest at least 80% of the value of its assets (net assets plus the amount of any borrowings for investment purposes) in equity securities of U.S. and foreign companies, principally common stocks and preferred stocks, identified by the Adviser as having growth characteristics. In identifying investments with growth characteristics, the Adviser utilizes a fundamental approach to choosing securities: the research staff of Emerald conducts company-specific research analysis, taking into account a companys revenue and earnings growth rates and the financial, operating, and market characteristics that distinguish a company from other companies. The Funds policy to invest at least 80% of its assets in such a manner is non-fundamental, which means that it may be changed without shareholder approval. Shareholders…
From the fund's prospectus (filed Sep 8, 2026).
FGROX performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| FGROX | +32.0% | +8.1% | +12.7% |
| Large Growth median | +15.2% | +11.0% | +14.2% |
Source: Fund prospectus, as of Dec 31, 2025
What FGROX costs
On a $10,000 investment, FGROX's 0.75% expense ratio costs about $75 a year. The prospectus estimates $963 in total costs over 10 years (assuming 5% annual returns). The median large growth fund charges 0.87%.
FGROX top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | F/m Emerald Life Sciences Inno LFSC | 6.14% |
| 2 | U.S. Bank Money Market Deposit Account | 1.98% |
| 3 | AAR Corp AIR | 1.95% |
| 4 | InterDigital Inc IDCC | 1.83% |
| 5 | Travere Therapeutics Inc TVTX | 1.69% |
| 6 | VSE Corp VSEC | 1.68% |
| 7 | Mercury Systems Inc MRCY | 1.63% |
| 8 | Corcept Therapeutics Inc CORT | 1.54% |
| 9 | ESCO Technologies Inc ESE | 1.51% |
| 10 | Sensient Technologies Corp SXT | 1.47% |
Source: SEC Form N-PORT, period ended Jul 31, 2026
The top 10 make up 21.4% of the fund. See all top 25 holdings and asset mix →